Insider · CIK 0001871423
Nicholas Maestas
Files at TPST (Tempest Therapeutics, Inc.), RANI (Rani Therapeutics Holdings, Inc.). First filing -, latest -.
In brief
Nicholas Maestas files SEC Form 4 as CFO at TPST (Tempest Therapeutics, Inc.), and also at RANI (Rani Therapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nicholas Maestas has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | RANI Rani Therapeutics Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,000,000 | $0.00 | $0 | 2,000,000 | Jul 21, 2026 |
| Mar 31, 2026 | TPST Tempest Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +140,000 | $0.00 | $0 | 140,000 | Apr 2, 2026 |
| Jan 3, 2024 | TPST Tempest Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 5, 2024 |
| Oct 11, 2023 | TPST Tempest Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Oct 13, 2023 |
Questions about Nicholas Maestas
Answered from the filings on this page, as of the latest one.
Is Nicholas Maestas buying or selling?
Nicholas Maestas has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nicholas Maestas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicholas Maestas has 0.
Where does Nicholas Maestas file Form 4?
Nicholas Maestas has filed Form 4 at TPST (Tempest Therapeutics, Inc.) as VP of Strategy and Finance; RANI (Rani Therapeutics Holdings, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.